Allegheny Financial Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.9M | Buy |
17,680
+10
| +0.1% | +$1.07K | 0.42% | 50 |
|
|
2025
Q1 | $1.78M | Sell |
17,670
-64
| -0.4% | -$6.46K | 0.46% | 42 |
|
|
2024
Q4 | $1.58M | Buy |
17,734
+64
| +0.4% | +$5.72K | 0.41% | 50 |
|
|
2024
Q3 | $1.48M | Hold |
17,670
| – | – | 0.37% | 50 |
|
|
2024
Q2 | $1.36M | Sell |
17,670
-1,362
| -7% | -$105K | 0.39% | 47 |
|
|
2024
Q1 | $1.3M | Buy |
19,032
+1,553
| +9% | +$106K | 0.4% | 47 |
|
|
2023
Q4 | $1.01M | Buy |
17,479
+7
| +0% | +$405 | 0.32% | 58 |
|
|
2023
Q3 | $923K | Buy |
+17,472
| New | +$923K | 0.35% | 56 |
|
|
2023
Q2 | – | Sell |
-17,278
| Closed | -$864K | – | 152 |
|
|
2023
Q1 | $864K | Hold |
17,278
| – | – | 0.35% | 60 |
|
|
2022
Q4 | $799K | Hold |
17,278
| – | – | 0.33% | 61 |
|
|
2022
Q3 | $669K | Hold |
17,278
| – | – | 0.31% | 65 |
|
|
2022
Q2 | $644K | Hold |
17,278
| – | – | 0.3% | 65 |
|
|
2022
Q1 | $765K | Sell |
17,278
-475
| -3% | -$21K | 0.32% | 62 |
|
|
2021
Q4 | $754K | Hold |
17,753
| – | – | 0.3% | 62 |
|
|
2021
Q3 | $770K | Hold |
17,753
| – | – | 0.35% | 52 |
|
|
2021
Q2 | $759K | Hold |
17,753
| – | – | 0.34% | 53 |
|
|
2021
Q1 | $686K | Buy |
+17,753
| New | +$686K | 0.5% | 38 |
|